1.29
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.26 -0.03 -2.33%
loading

Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
16.08%
17.67
21.05 16.14 15.52 14.39
Operating Income/Loss
16.08%
-17.67
-21.05 -16.14 -15.52 -14.39
Nonoperating Income/Loss
1.182
- 1.671 1.606 1.637
Income/Loss From Continuing Operations Before Tax
14.37%
-16.49
-19.25 -14.47 -13.91 -12.76
Income/Loss From Continuing Operations After Tax
14.37%
-16.49
-19.25 -14.47 -13.91 -12.76
Net Income/Loss
14.37%
-16.49
-19.25 -14.47 -13.91 -12.76
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
25,962%
22.59
0.0867 22.08 21.97 21.92
Diluted Average Shares
25,962%
22.59
0.0867 22.08 21.97 21.92
Basic Earnings Per Share
16.09%
-0.73
-0.87 -0.66 -0.63 -0.58
Diluted Earnings Per Share
16.09%
-0.73
-0.87 -0.66 -0.63 -0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):